双酚A对斑马鱼精巢性激素生成酶基因表达的影响

为了解环境雌激素对鱼类精巢发育的影响,将成年雄性斑马鱼(Danio rerio)暴露于不同浓度双酚A(0、500、1 000、2 000、4 000μg·L-1)下21 d,并在此基础上,进一步研究了暴露在相同浓度(BPA2 000μg·L-1)不同暴露时间下各基因表达的动力学模式。用荧光定量PCR(qRT-PCR)方法检测试验鱼精巢性激素合成相关细胞色素P450酶类基因(CYP17、CYP11B和CYP19A)以及雌、雄激素受体和促卵泡激素受体(ERα、ERβ、AR和FSHR)基因的表达,用常规组织学方法研究试验鱼精巢结构的变化。结果表明,BPA促进了精巢内源雌激素合成相关酶类基因CYP19A和雌激素受体ERαmRNA、ERβmRNA的表达,且BPA浓度为2 000μg·L-1时3者的表达量显著上调,同时随着暴露时间的延长,具有明显的时间累积效应。1 000μg·L-1BPA可导致斑马鱼精巢CYP17 mRNA的表达量显著下调,BPA2 000μg·L-1暴露12 d引起了CYP11B mRNA表达下调,而随着暴露时间的延长有所回升,但它对精巢AR mRNA的表达却无明显影响。同时,BPA 500μg·L-1引起了FSHR基因的显著上调,在时间动态学上,呈上升趋势。在组织学上,2 000μg·L-1BPA引起斑马鱼精巢生精小管内精子浓缩严重,精原细胞(Sg)和精母细胞(PS和SS)数目都有所减少,BPA 4 000μg·L-1组斑马鱼精巢退化。因此,BPA可诱导精巢内源雌激素合成和雌激素受体的表达,提高雌激素效应,通过抑制CYP17基因的表达,一定程度上抑制雄激素的合成,从而引起斑马鱼精巢组织的破坏。同时,据实验数据推测,雄激素的下调可能启动了下丘脑-垂体-性腺(HPG)轴的负反馈调节机制,而此作用机制还有待进一步研究。     

Acrylamide and its metabolite glycidamide can affect antioxidant defenses and steroidogenesis in Leydig and Sertoli cells

Acrylamide, which is commonly used in various industries, may also form in food products cooked in high temperatures. Glycidamide, the ultimate genotoxic metabolite of acrylamide, is generated within cells through CYP4502E1-mediated epoxidation. Recent studies have shown that acrylamide and/or glycidamide may cause infertility by disrupting spermatogenesis, decreasing germ cell production and sperm fertilization ability due to their toxic effects on the male reproductive system. This study aimed to determine some direct effects of acrylamide and glycidamide on antioxidant defenses and on steroidogenic enzymes of Leydig and Sertoli cells. For this purpose, mouse Leydig and Sertoli cells were exposed to acrylamide (0.01 or 1?mmol/L) or to glycidamide (0.001 or 0.5?mmol/L) for 24?h. Following the exposure, antioxidant enzyme activities (catalase, superoxide dismutase, glutathione peroxidase and γ-glutamyl transpeptidase), cellular antioxidant levels (glutathione) and steroidogenic enzyme activities (3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase) were calculated. It was shown that acrylamide and glycidamide may cause inhibition of antioxidant and steroidogenic enzymes in Leydig and Sertoli cells. In conclusion, acrylamide and glycidamide may alter testicular function, thereby disrupting male reproduction.     

The OECD Validation Program of the H295R Steroidogenesis Assay for the Identification of In Vitro Inhibitors and Inducers of Testosterone and Estradiol Production. Phase 2: Inter-Laboratory Pre-Validation Studies (8 pp)

Background, Goals and Scope In response to concerns that have been raised about chemical substances that may alter the function of endocrine systems and result in adverse effects on human health, an OECD initiative was undertaken to develop and validate in vitro and in vivo assays to identify chemicals that may interfere with endocrine systems of vertebrates. Here we report on studies that were conducted to develop and standardize a cell-based screening assay using the H295R cell line to prioritize chemicals that may act on steroidogenic processes in humans and wildlife. These studies are currently ongoing as part of the ‘Special Activity on the Testing and Assessment of Endocrine Disruptors’ within the OECD Test Guidelines Program to review, develop, standardize, and validate a number of in vitro and in vivo toxicological assays for testing and assessment of chemicals concerning their potential to interact with the endocrine system of vertebrates. Study Design Six laboratories from five countries participated in the pre-validation studies. Each laboratory tested the effects of three model chemicals on the production of testosterone (T) and estradiol (E2) using the H295R Steroidogenesis Assay. Chemicals tested were well described inducers or inhibitors of steroidogenic pathways (forskolin, prochloraz and fadrozole). All experiments were conducted in 24 well plates following standard protocols. Six different doses per compound were analyzed in triplicate per plate. A quality control (QC) plate was run in conjunction with the chemical exposure plate to account for inter-assay variation. Each chemical exposure was conducted two or three times. Results All laboratories successfully detected increases and/or decreases in hormone production by H295R cells after exposure to the different model compounds and there was good agreement in the pattern of response for all groups. Forskolin increased both T and E2 while fadrozole and prochloraz decreased production of both hormones. All chemicals affected hormone production in a dose-dependent manner with the exception of fadrozole which caused maximum inhibition of E2 at the two least concentrations tested. Some inter-laboratory differences were noted in the alteration of hormone production measured in chemically exposed cells. However, with the exception of the production of T measured at one laboratory in cells exposed to forskolin, the EC₅₀s calculated were comparable (coefficients of variation 34–49%) for all hormones. Discussion and Perspectives The results indicated that the H295R Steroidogenesis Assay protocol was robust, transferable and reproducible among all laboratories. However, in several instances that were primarily related to one laboratory there were unexplained minor uncertainties related to the inter-laboratory hormone production variation. Based on the findings from this Phase 2 prevalidation study, the H295R Steroidogenesis Assay protocol is currently being refined. The next phase of the OECD validation program will test the refined protocol among the same group of laboratories using an extended set of chemicals (∼30) that will include positive and negative chemical controls as well as a broad spectrum of different potential inducers and inhibitors of steroidogenic pathways. Submission Editor: Dr. Carsten Brühl (bruehl@uni-landau.de)